Drug Approval | May 07, 2026
Venus Remedies gets marketing authorization for Ceftriaxone in Argentina
Approval strengthens the company’s growing international anti-infective portfolio
Approval strengthens the company’s growing international anti-infective portfolio
Supported by Plan International, the partnership will help treat over 1,000 children annually
The standout story remains Wegovy, particularly its new oral formulation
The company informed stock exchanges that the appellate authority has set aside the GST demand along with applicable interest and penalty
The company reported robust revenue and profit growth for FY26, supported by strong CDMO performance, improving margins, and expansion across advanced manufacturing platforms
Fresenius Kabi's approved generic therapy addresses acute symptomatic hypocalcemia and targets a US market valued at nearly $71 million
Pharma major reports FY26 revenue of Rs 9,204 crore with 16.6% growth
The initiative aims to encourage women and parents to seek timely medical guidance on cervical cancer prevention and HPV awareness
More than 3,500 participants will join the nationwide AI-focused hackathon hosted as Indian Institute of Science
The conference brought together over 500 doctors and 150 nutritionists to discuss emerging obesity-related challenges
Subscribe To Our Newsletter & Stay Updated
